Positions
- Dean for the National School of Tropical Medicine
-
ÌÇÐÄvlogÃÛÌÒ of Medicine
Houston, United States
- Professor
-
Departments of Pediatrics and Molecular Virology & Microbiology
ÌÇÐÄvlogÃÛÌÒ of Medicine
Houston, Texas, United States
- Endowed Chair in Tropical Pediatrics
-
Texas Children's Hospital
Houston, Texas, United States
- Co-Director
-
Texas Children's Hospital Center for Vaccine Development
Houston, Texas, United States
- Founding Editor in Chief
-
PLOS Neglected Tropical Diseases
- University Professor
-
Baylor University
Houston, Texas, United States
- Fellow in Disease and Poverty
-
James A. Baker III Institute for Public Policy
Rice University
Houston, Texas, United States
- Health Policy Scholar
-
Center for Medical Ethics and Health Policy
ÌÇÐÄvlogÃÛÌÒ of Medicine
- Faculty-Senior Fellow
-
Hagler Institute for Advanced Study & Scowcroft Institute of Intl Affairs
Texas A&M University
Education
- M.D. from Weill Cornell Medical College
- 05/1987 - New York, NY, United States
- Ph.D. from The Rockefeller University
- 05/1986 - New York, NY, United States
- B.A. (magna cum laude) from Yale University
- 05/1980 - New Haven, Connecticut, United States
Professional Interests
- Drug and Vaccine Delivery
- Tropical Medicine
Projects
- Coronavirus Vaccines
- Development of coronavirus vaccines including vaccines administered to over 100 million people in India and Indonesia. Ongoing work includes research on a multivalent pan-coronavirus vaccine to protect against multiple coronavirus variants.
- Human Hookworm Vaccine
- Development of a vaccine for the more than 400 million people suffering from hookworm infection in the world today. Vaccine currently in phase 1 clinical trials in Brazil and Gabon.
- Schistosomiasis Vaccine
- Schistosomiasis afflicts over 200 million people around the globe and is the deadliest disease among the seven most prevalent NTDs, killing an estimated 280,000 people annually. Our vaccine is entering phase 1 clinical trials.
- Chagas Disease and Leishmaniasis Vaccine
- A project for the selection and discovery of antigens appropriate to advance into the development process of new vaccines to combat Chagas disease (American trypanosomiasis) and leishmaniasis.
- SARS Vaccine
- A new vaccine to prevent severe acute respiratory syndrome (SARS). A prototype RBD219 N1 vaccine is entering scale-up process development
- Multivalent Anthelmintic Vaccine Discovery
- A panhelmintic vaccine to prevent ascariasis (roundworm) and trichuris (whipworm), soil-transmitted helminths afflicting hundreds of millions of people around the world.
to edit your profile